During a Senate hearing, Health and Human Services Secretary Robert F. Kennedy Jr. stated his agreement that mRNA vaccines, such as those for COVID-19, cause serious harm, including death. Kennedy, a known anti-vaxxer, responded to questions about a new member of the CDC vaccine advisory committee who made a similar claim. He then sparred with several senators over the number of COVID-19 deaths in America and the effectiveness of the vaccines, demonstrating a lack of knowledge and acceptance of established data. This led to strong criticism from the senators present at the hearing.
Read More
According to a source close to Robert F. Kennedy Jr., the Trump administration is planning to remove the COVID vaccine from the U.S. market “within months.” Dr. Aseem Malhotra, an advisor to the Make America Healthy Again Action group, stated that this decision is supported by “influential” members of Trump’s family and is based on concerns regarding vaccine injuries. This move is expected to be implemented in stages, potentially pending further research and could create legal and public health issues. This plan is spurred by a peer-reviewed paper that suggests mRNA vaccines carry a higher risk of adverse events, however, many members of the medical community disagree with its findings.
Read More
Former Surgeon General Dr. Jerome Adams criticized the decision to cut funding for mRNA vaccine development, arguing it would lead to preventable deaths. Adams, who served during the Trump administration, stated that the mRNA technology, which was critical to Operation Warp Speed, has saved millions of lives and is essential for future medical advancements. He refuted Secretary Kennedy’s claims about the ineffectiveness of mRNA vaccines and highlighted their importance in combating various diseases. Additionally, Adams criticized Kennedy’s response to the Atlanta CDC shooting, stating the Health Secretary has failed in his first major test.
Read More
The U.S. government, under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., has cancelled nearly $500 million in contracts for mRNA vaccine development, a move celebrated by anti-vaccine advocates despite contradicting scientific evidence. Kennedy claimed the cancellation was due to the vaccines’ ineffectiveness against respiratory infections, a claim refuted by health experts like Michael Osterholm. The decision has been met with concern, as it jeopardizes the ability to combat future pandemics and undermines national security, as well as essential government investment in vaccine development.
Read More
The Department of Health and Human Services (HHS) will be canceling contracts and pulling funding from 22 mRNA vaccine projects, totaling $500 million, to combat respiratory viruses. This decision, led by the health secretary, is based on the belief that safer and broader vaccine strategies, such as whole-virus vaccines, are better. Infectious disease experts have criticized the decision, citing the safety and efficacy of mRNA technology, which was critical in slowing the 2020 coronavirus pandemic, and its potential for future pandemic response. HHS maintains that this signals a shift in priorities and will focus on developing a “universal vaccine” that mimics “natural immunity.”
Read More
The Associated Press, established in 1846, is a globally recognized, independent news organization committed to factual reporting. It is considered a highly trusted source for accurate and unbiased news across all formats, providing essential technology and services to the news industry. AP’s content reaches over half the world’s population daily.
Read More
House Bill 371, sponsored by Rep. Kmetz and others, passed the House Judiciary Committee along party lines and heads to the House floor. This bill would prohibit the use of mRNA vaccines for infectious diseases in Montana, classifying the technology as hazardous. While proponents claim the vaccines cause more harm than benefit, opponents argue the bill infringes on patient choice and medical professional autonomy, limiting access to safe and effective disease prevention. The bill was amended to exclude mRNA gene therapy products used for other conditions.
Read More
AstraZeneca, a prominent player in the race to develop a COVID-19 vaccine, has made a significant announcement to withdraw its vaccine globally, according to reports from The Telegraph. This decision comes amidst a backdrop of shifting preferences where vaccines from Pfizer and Moderna have become more accessible and favored by the public. While AstraZeneca initially had the advantage of easier storage requirements compared to its counterparts, recent developments have led to its diminishing popularity.
Research indicates that the AstraZeneca vaccine has been associated with a higher risk of blood clots, prompting concerns among the public. The British Heart Foundation highlights that for every 10 million individuals vaccinated with AstraZeneca, there are additional cases of blood clots compared to the occurrence of similar conditions with a COVID-19 infection.… Continue reading
John Q. Hosedrinker